MedImpact Earns URAC PBM Accreditation
San Diego, CA – March 11, 2026 – MedImpact Healthcare Systems, Inc., the nation’s largest independent pharmacy benefit manager and health solutions company, announced today that it has received URAC’s three-year full pharmacy benefit management (PBM) accreditation — marking the company’s sixth consecutive accreditation.
MedImpact achieved a score of 100% for the fourth consecutive accreditation cycle.
URAC is the independent leader in promoting healthcare quality by setting high standards for clinical practice, consumer protections, performance measurement, operations infrastructure, and risk management.
By achieving this accreditation, MedImpact has demonstrated its commitment to quality care, enhanced processes, patient safety and improved outcomes.
“This milestone highlights not only MedImpact’s unwavering commitment to excellence in pharmacy benefit management, operational integrity, and continuous improvement in healthcare quality, but it also underscores our focus on delivering client-centered excellence,” said Denise Burns, Chief Operating Officer, MedImpact.
URAC accreditation is a symbol of excellence and signifies that MedImpact’s programs and processes have been rigorously evaluated and are at the forefront of industry PBM services.
“The URAC Pharmacy Benefit Management accreditation seal shows an organization’s commitment to high quality in healthcare in the areas of risk management, consumer protection and empowerment, operations and infrastructure, as well as performance management and improvement. We are proud to recognize MedImpact for their achievement in these areas,” said URAC President and CEO, Shawn Griffin, MD.
Government programs are growing more complex and harder to manage, often serving populations with higher health risks and costs.
Improving outcomes, controlling costs, and navigating evolving quality measures are ongoing challenges facing health plans.
